As of 2025-08-06, the EV/EBITDA ratio of Ajanta Pharma Ltd (AJANTPHARM.NS) is 24.48. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AJANTPHARM.NS's latest enterprise value is 327,949.56 mil INR. AJANTPHARM.NS's TTM EBITDA according to its financial statements is 13,396.70 mil INR. Dividing these 2 quantities gives us the above AJANTPHARM.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 23.6x | 21.0x |
| Forward P/E multiples | 15.2x - 20.2x | 18.2x |
| Fair Price | 1,943.40 - 2,587.77 | 2,292.10 |
| Upside | -26.3% - -1.8% | -13.0% |
| Date | EV/EBITDA |
| 2025-08-04 | 24.48 |
| 2025-08-01 | 25.03 |
| 2025-07-31 | 25.47 |
| 2025-07-30 | 26.04 |
| 2025-07-29 | 26.26 |
| 2025-07-28 | 25.56 |
| 2025-07-25 | 25.93 |
| 2025-07-24 | 26.00 |
| 2025-07-23 | 25.21 |
| 2025-07-22 | 25.40 |
| 2025-07-21 | 25.75 |
| 2025-07-18 | 25.75 |
| 2025-07-17 | 25.85 |
| 2025-07-16 | 25.78 |
| 2025-07-15 | 25.13 |
| 2025-07-14 | 24.61 |
| 2025-07-11 | 24.30 |
| 2025-07-10 | 24.01 |
| 2025-07-09 | 24.41 |
| 2025-07-08 | 24.22 |
| 2025-07-07 | 24.64 |
| 2025-07-04 | 25.13 |
| 2025-07-03 | 24.47 |
| 2025-07-02 | 23.68 |
| 2025-07-01 | 23.25 |
| 2025-06-30 | 23.91 |
| 2025-06-27 | 23.57 |
| 2025-06-26 | 23.87 |
| 2025-06-25 | 24.00 |
| 2025-06-24 | 23.75 |
| 2025-06-23 | 23.83 |
| 2025-06-20 | 24.05 |
| 2025-06-19 | 23.49 |
| 2025-06-18 | 23.92 |
| 2025-06-17 | 23.53 |
| 2025-06-16 | 24.12 |
| 2025-06-13 | 24.45 |
| 2025-06-12 | 25.25 |
| 2025-06-11 | 24.55 |
| 2025-06-10 | 23.83 |
| 2025-06-09 | 24.02 |
| 2025-06-06 | 23.89 |
| 2025-06-05 | 23.98 |
| 2025-06-04 | 23.94 |
| 2025-06-03 | 23.77 |
| 2025-06-02 | 23.75 |
| 2025-05-30 | 23.31 |
| 2025-05-29 | 23.87 |
| 2025-05-28 | 23.96 |
| 2025-05-27 | 23.98 |